Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 182 results found. Search for [ Sputnik V trials in India ]

Results 1 to 21 of 182
PB Jayakumar
March 3, 2021
So far, the Pfizer-BioNTtech and Moderna vaccines, made through a novel platform technology never used in humans before, are proven to have maximum efficacy


BusinessToday.In
February 24, 2021
Biological E has tied up with vaccine maker Johnson & Johnson and Baylor College of Medicine in Houston. And, it plans to start the Phase 3 trial of the candidate licensed from Baylor College next week


BusinessToday.In
February 19, 2021
As part of the review process, Dr Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by 21st February 2021.


Rashi Bisaria
New Delhi, February 16, 2021
Revival in job market: January sees 50% rise in vacancies over December Vaccination drive against COVID-19 and improving economic indicators has enthused employers to recruit. This was evident in a survey which showed job openings increased almost 50 per cent in January as compared to December. Vacancies in January rose to 265,000 from 180,000 in December, according to Xpheno's Active Job Outlook survey. COVID-19 vaccine: Russia's Sputnik V may be approved by India in next few weeks Ind...


BusinessToday.In
February 15, 2021
Earlier, Dr Reddy's had said it expects to roll out Sputnik V vaccine in India in March via Emergency Use Authorisation (EUA) after the completion of Phase 3 trials.


BusinessToday.In
February 3, 2021
Earlier, The Lancet had stated that Russia's experimental COVID-19 vaccine Sputnik V is 91.6 per cent affective against coronavirus infection. These results are based on Phase 3 trials of the vaccine in which 20,000 people had participated


BusinessToday.In
February 3, 2021
The pharma stock touched an intraday high of Rs 4,759.1 rising 6.13% against previous close of Rs 4,484.25 on BSE


Shailendra Shukla
New Delhi, February 3, 2021
Oxford Languages names 'Aatmanirbharta' as Hindi Word of 2020 Oxford Languages has named 'Aatmanirbharta' as its Hindi Word of the Year 2020. The word gained significance after Prime Minister Narendra Modi emphasised on 'Aatmanirbharta' (self-reliance) as a response to the COVID-19 pandemic last year. According to the dictionary publisher, 'Aatmanirbharta' was chosen as it \"validated the day-to-day achievements of the countless Indians who dealt with and survived the perils of a pandemic\"...


BusinessToday.In
February 2, 2021
The Gam-COVID-Vac, called Sputnik V, is a two-part vaccine that includes two adenovirus vectors - recombinant human adenovirus type 26 (rAd26-S) and recombinant human adenovirus type 5 (rAd5-S).


Reuters
February 2, 2021
The dosing mishap was presented to the trial participants in a letter dated June 8 as an opportunity for University of Oxford researchers to learn how well the vaccine works at different doses


BusinessToday.In
January 30, 2021
Coronavirus vaccine: J&J plans to seek emergency use authorisation from the US Food and Drug Administration next week. It has said it plans to deliver 1 billion doses in 2021 and will produce the vaccine in the United States, Europe, South Africa and India


BusinessToday.In
January 30, 2021
Sputnik V is undergoing Phase-3 trials in India currently which is expected to be completed by February


BusinessToday.In
January 29, 2021
Dr Reddy's Labs share closed 5.69% or Rs 277 lower at Rs 4,598 against previous close of Rs 4,876 on BSE


BusinessToday.In
January 25, 2021
As per the government's norms, it is mandatory for a foreign vaccine-making firm to conduct at least a Phase-3 trial with Indian volunteers even if it is approved outside India


BusinessToday.In
January 22, 2021
Dmitriev said Sputnik V's $10 price tag is not only affordable but also half to one-third of other vaccines and has an efficacy rate of more than 90 per cent


BusinessToday.In
January 20, 2021
Coronavirus vaccination drive: Dr RS Sharma, chairman of the empowered group on COVID-19 vaccination said the average vaccination sessions of 100 were allowed per site but in some centres fewer people were turning up


Reuters
January 19, 2021
Russia began testing EpiVacCorona, which is being developed by Siberia's Vector Institute, in November


BusinessToday.In
January 19, 2021
COVID-19 immunisation in Delhi: The sharp drop in immunisations comes after 51 adverse events following immunization - one severe and 50 minor cases were reported from Delhi on Saturday


PTI
January 16, 2021
Speaking at the 25th Wharton India Economic Forum, he said the Indian pharma industry ensured the continuity of supplies


BusinessToday.In
January 16, 2021
Sputnik V vaccine phase 3: The Data and Safety Monitoring Board (DSMB) had reviewed the safety data from phase 2 trials of the vaccine and stated that there were no safety concerns attached to the jab earlier this week


PAGES 1 OF 10  12345